Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
11
×
life sciences
national blog main
national top stories
11
×
san francisco blog main
san francisco top stories
boston blog main
boston top stories
biotech
cancer
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
fda
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
deals
sanofi
amgen
cancer drugs
glaxosmithkline
investing
ipo
loxo oncology
sage therapeutics
What
cancer
11
×
drug
medicines
roundup
bio
fda
ipo
ahead
cash
days
immunotherapy
marketing
medicine
new
pharmaceutical
proteins
reach
research
revolution
targets
abbvie’s
advanced
aim
ambien
american
annual
appetite
approval
approved
arrival
asco
attendees
attention
award
biofourmis
biotech
black
blood
blueprint
boost
Language
unset
Current search:
cancer
×
" clinical trials "
×
" national top stories "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More